Healthcare >> Analyst Interviews >> May 8, 2002

Biotechnology Patent Law: An Overview: Kevin Noonan – Mcdonnell Boehnen Hulbert & Berghoff

KEVIN E. NOONAN has extensive experience in biotechnology and the chemical arts. A registered patent agent since 1991, Dr. Noonan brings over 10 years' experience as a molecular biologist working on high-technology problems to his legal work. Dr. Noonan has wide experience in all aspects of patent prosecution and client counseling on validity, infringement, and patenting strategy matters. He represents pharmaceutical and biotechnology companies both large and small, and is particularly experienced in representing university clients in both patent prosecution and licensing to outside investors. Dr. Noonan received a PhD in Molecular Biology from Princeton University, where his thesis work involved genetic analysis of oncogenesis in mammalian cells. Dr. Noonan was also a Postdoctoral Fellow supported by the National Cancer Institute at the University of Illinois at Chicago, where he studied multidrug resistance in mammalian tumor cells. During his fellowship, Dr. Noonan developed a variety of novel methods based on the polymerase chain reaction, including quantitative analysis of mammalian gene expression. Dr. Noonan is the author of several articles and has lectured extensively on his scientific work. He graduated, cum laude, from the John Marshall Law School and he is admitted to practice in Illinois and Massachusetts. Dr. Noonan is currently an Adjunct Professor of Law at the De Paul University Law School, where he teaches biotechnology patent law. Profile
TWST: Can we start out with a quick overview of your practice and

what you're doing?

Dr. Noonan: I do the whole range of IP representation for

clients, from patent prosecution and client